Log In
Print
BCIQ
Print
Print this Print this
 

levodopa/carbidopa/entacapone (ODM-101)

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionOptimized formulation of levodopa plus dopa decarboxylase (DDC) inhibitor and catechol-O-methyl-transferase (COMT) inhibitor
Molecular Target
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today